secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2026-10-09T21:15:59+00:00
Accession:  0001640334-26-001665
Event type: regulatory
Sentiment:  negative
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Artelo named among ~180 Nasdaq companies below new $5M MVLS threshold; rule stay means no immediate delisting
--------------------------------------------------------------------------------

- SEC approved Nasdaq's new $5M market value of listed securities (MVLS) rule on July 22, 2026; ~180 Nasdaq companies including Artelo were initially identified as below the threshold.
- A temporary stay of the $5M MVLS Rule was announced July 29, 2026; on Oct 5, 2026 the SEC published Nasdaq's proposed change to make the rule operative upon stay termination.
- Comments on the proposed rule change are due by October 29, 2026; Artelo says it has no information on how long the stay lasts or whether the rule returns in current form.
- Remedies cited if the rule applies: ATM equity offering or other equity-linked financings, actions on outstanding warrants, advancing development programs, managing operating expenses.
- Artelo said it has not committed to any particular course of action and does not intend further disclosure unless it deems it appropriate or required.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426001665/0001640334-26-001665-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426001665/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-26-001665

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer